Pheton Holdings Ltd. (ITOC)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Pheton Holdings Ltd. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 10,852 | $4,567 | $3,366.29 | -$1,200.71 | -26.29% |
Pheton Holdings Ltd. (ITOC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Pheton Holdings Ltd. ever had a stock split?
Pheton Holdings Ltd. Profile
| Household Durables Industry | Consumer Discretionary Sector | Jianfei Zhang CEO | NASDAQ (CM) Exchange | G71399102 CUSIP |
| CN Country | 7 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
iTonic Holdings Ltd. is a leading healthcare solutions provider that specializes in the development and commercialization of software and devices specifically designed for brachytherapy, a form of radiotherapy used in cancer treatment. The company is known for its innovative approach to creating proprietary treatment planning systems that facilitate the implantation of radioactive particles within patients, effectively targeting and destroying cancer cells while minimizing damage to surrounding healthy tissues. Established in 1998 and headquartered in Beijing, China, iTonic Holdings Ltd. has grown into a critical player in the oncology sector, focusing on advanced treatment methodologies for improving patient outcomes. Formerly known as Pheton Holdings Ltd., the company rebranded to iTonic Holdings Ltd. in January 2026, and now operates as a subsidiary of ZJW (BVI) LTD.
Products and Services
- FTTPS (Treatment Planning System)
FTTPS is an advanced treatment planning system tailored for the effective management of various malignant tumors. It plays a crucial role in brachytherapy by enabling healthcare professionals to determine the target volume, specify prescription doses, and set dose limitations to safeguard organs at risk. The system is designed to produce precise dose distribution plans, ensuring that patients receive optimal treatment tailored to their specific medical needs.
- Radioactive Particle Implantation
This innovative technique involves the strategic placement of radioactive sources inside a patient’s body, allowing for targeted radiotherapy to kill cancer cells and diminish tumors. This method enhances local control of the disease while preserving healthy tissue, making it a preferred option for oncologists treating cancer patients.
- Consultation and Technical Support
iTonic Holdings Ltd. provides ongoing consultation and technical support to healthcare facilities utilizing their treatment planning systems and devices. This service ensures that medical practitioners receive comprehensive guidance in implementing brachytherapy techniques, maximizing treatment effectiveness and enhancing patient care.
- Education and Training Programs
The company offers educational programs designed to train healthcare professionals in the latest brachytherapy techniques and the use of their proprietary software. These programs aim to equip oncologists and medical staff with the knowledge and skills necessary to leverage advanced treatment options, ultimately improving patient outcomes.
